155 related articles for article (PubMed ID: 31257939)
1. Pharmacist Comfort and Awareness of HIV and HCV Point-of-Care Testing in Community Settings.
Min AC; Andres JL; Grover AB; Megherea O
Health Promot Pract; 2020 Sep; 21(5):831-837. PubMed ID: 31257939
[TBL] [Abstract][Full Text] [Related]
2. Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center.
Isho NY; Kachlic MD; Marcelo JC; Martin MT
J Am Pharm Assoc (2003); 2017; 57(3S):S259-S264. PubMed ID: 28506379
[TBL] [Abstract][Full Text] [Related]
3. Patient awareness, willingness, and barriers to point-of-care hepatitis C screening in community pharmacy.
Brewer A; Hanna C; Eckmann L; Schadler A; Divine H
J Am Pharm Assoc (2003); 2018; 58(4S):S69-S72.e1. PubMed ID: 30006188
[TBL] [Abstract][Full Text] [Related]
4. Pharmacists performing hepatitis C antibody point-of-care screening in a community pharmacy: A pilot project.
Dong BJ; Lopez M; Cocohoba J
J Am Pharm Assoc (2003); 2017; 57(4):510-515.e2. PubMed ID: 28602784
[TBL] [Abstract][Full Text] [Related]
5. Innovating the Model for Student Pharmacists to Increase Access to Hepatitis C Testing (Project IMPACT).
Januszka J; Notarianni V; Devenny E; Harris E
J Am Pharm Assoc (2003); 2023; 63(4):1217-1221. PubMed ID: 37037394
[TBL] [Abstract][Full Text] [Related]
6. Time and motion study of hepatitis C virus point-of-care testing in community pharmacies.
Beuschel T; Gootee E; Jordan M; Sikkenga T; Klepser DG; Holmquist H; de Voest A; Klepser ME
J Am Pharm Assoc (2003); 2023; 63(1):435-439. PubMed ID: 36463010
[TBL] [Abstract][Full Text] [Related]
7. Feasibility and outcomes of a hepatitis C screening programme in community pharmacies.
Gauld N; Perry J; Jackson C; Gane E
N Z Med J; 2020 Nov; 133(1525):74-83. PubMed ID: 33223550
[TBL] [Abstract][Full Text] [Related]
8. Pharmacists' Opinions on the Implementation of HIV and HepC Point-of-Care-Testing in a U.S. Pharmacy Chain.
So E; Brands M; Suomala E; Ogden B; Riss J; Cernasev A; Schommer J
Innov Pharm; 2019; 10(1):. PubMed ID: 34007531
[TBL] [Abstract][Full Text] [Related]
9. Implementation and Evaluation of a Collaborative, Pharmacy-Based Hepatitis C and HIV Screening Program.
Klepser DG; Klepser ME; Peters PJ; Hoover KW; Weidle PJ
Prev Chronic Dis; 2022 Dec; 19():E83. PubMed ID: 36480802
[TBL] [Abstract][Full Text] [Related]
10. Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy.
Gubbins PO; Klepser ME; Dering-Anderson AM; Bauer KA; Darin KM; Klepser S; Matthias KR; Scarsi K
J Am Pharm Assoc (2003); 2014; 54(2):163-71. PubMed ID: 24632931
[TBL] [Abstract][Full Text] [Related]
11. Point-of-Care Testing in Community Pharmacies: Keys to Success From Pennsylvania Pharmacists.
Steltenpohl EA; Barry BK; Coley KC; McGivney MS; Olenak JL; Berenbrok LA
J Pharm Pract; 2018 Dec; 31(6):629-635. PubMed ID: 29034781
[TBL] [Abstract][Full Text] [Related]
12. Expanding access to HIV testing through Canadian community pharmacies: findings from the APPROACH study.
Kelly DV; Kielly J; Hughes C; Gahagan J; Asghari S; Hancock S; Burt K; Smyczek P; Charlton C; Nguyen H
BMC Public Health; 2020 May; 20(1):639. PubMed ID: 32380978
[TBL] [Abstract][Full Text] [Related]
13. Point-of-care HIV and hepatitis screening in community pharmacies: a quantitative and qualitative study.
Figueira I; Teixeira I; Rodrigues AT; Gama A; Dias S
Int J Clin Pharm; 2022 Oct; 44(5):1158-1168. PubMed ID: 36098836
[TBL] [Abstract][Full Text] [Related]
14. Pharmacists' perspectives on HIV testing in community pharmacies.
Ryder PT; Meyerson BE; Coy KC; von Hippel CD
J Am Pharm Assoc (2003); 2013; 53(6):595-600. PubMed ID: 24091415
[TBL] [Abstract][Full Text] [Related]
15. Training student pharmacists to facilitate human immunodeficiency virus point-of-care testing.
Staudt AM; Draime JA; Deitschmann N; Norfolk M; Jenkins ZN
Curr Pharm Teach Learn; 2020 Oct; 12(10):1245-1251. PubMed ID: 32739062
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C screening in a community pharmacy setting: Patient perspective.
Pegump KN; Nichols RE; Polgreen LA; Veach SR; Crowner AB; Witry MJ
J Am Pharm Assoc (2003); 2023; 63(4S):S78-S82. PubMed ID: 36804712
[TBL] [Abstract][Full Text] [Related]
17. Patient satisfaction with the clinical pharmacist and prescribers during hepatitis C virus management.
Martin MT; Faber DM
J Clin Pharm Ther; 2016 Dec; 41(6):645-649. PubMed ID: 27578276
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of a community pharmacy-based health and wellness introductory pharmacy practice experience.
McDowell L; Helmer R; Stevenson TL; Sierko A; Braxton Lloyd K
J Am Pharm Assoc (2003); 2022; 62(1):63-70. PubMed ID: 34756690
[TBL] [Abstract][Full Text] [Related]
19. Perceptions of pharmacists' role in the health care team through student-pharmacist led point-of-care screenings and its future application in health care.
Bastianelli KMS; Nelson L; Palombi L
Curr Pharm Teach Learn; 2017; 9(2):195-200. PubMed ID: 29233403
[TBL] [Abstract][Full Text] [Related]
20. Examining community-based pharmacist perceptions on the care of transgender patients.
Aragon KG; Conklin J; Lenell A; Rhodes LA; Marciniak MW
J Am Pharm Assoc (2003); 2019; 59(4S):S62-S66. PubMed ID: 31203014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
